RASP-UK - Moving away from the ‘one size fits all’ approach to treatment in severe asthma

News

 

June 2023

Scientific and Clinical Outcomes and Impact of the United Kingdom Refractory Asthma Stratification Programme (RASP-UK)

November 2021

WS4 Mepolizumab Exacerbation (MEX) study primary manuscript published in Lancet Respiratory Medicine

May 2021

WS4 Mepolizumab Exacerbation (MEX) study primary manuscript published in Lancet Respiratory Medicine

January 2021

Summary of the WS4 MAPLE study published in Thorax

October 2020

VIDEO: Prof. Heaney gives an overview of the WS1 Biomarker stratification study and the emerging results

Pivotal WS1 Biomarker Stratification study primary manuscript published in the Lancet Respiratory Medicine

Summary of the WS1 Biomarker Stratification study primary manuscript by the American Pharmacists Association

September 2020

Summary of the WS1 Biomarker Stratification Study primary manuscript presented at ERS 2020

Summary of the WS4 MEX study presented at ERS 2020

Summary of the WS4 MAPLE study presented at ERS 2020

Primary manuscript for the GSK connected inhaler study published in the ERJ

September 2019

Summary of the GSK connected inhaler study badged to WS1 presented at ERS 2020

April 2019

Perspective article summarising the un-met needs in severe asthma and outlining current and potential future research in severe asthma

January 2019

Editorial from the Journal of Allergy and Clinical Immunology

December 2018

Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus

Manuscript published in European Respiratory Journal.

Sorting Out Nonadherence and Airway Inflammation in Treatment Escalation for Severe Asthma

Editorial from: American Journal of Respiratory and Critical Care Medicine.

October 2018

Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Non-Adherence in Severe Asthma

January 2018

Methodology paper for workstrand 1 of the RASP consortium

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.

June 2017

Methodology paper for workstrand 1 of the RASP consortium

In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique improve clinical decision making? A protocol for a randomised controlled trial using electronic monitoring.

March 2017

Severe Asthma Report 2017 (Asthma UK)

A white paper describing RASP and how action is urgently needed to improve the prospects for people with severe asthma.

FYI News: Asthma UK discusses RASP

Asthma UK describes how action is urgently needed to improve the prospects for people with severe asthma.

November 2016

Twitter feed initiated

Keep informed of the latest findings to emerge from RASP

May 2016

RASP-UK on World Asthma Day

Noting the contribution of RASP in understanding severe asthma.

March 2016

Article on NIHR website about Work Strand 3 - 7 March 2016

Study offers hope for people with severe allergic asthma.

October 2015

Drug therapies in severe asthma – the era of stratified medicine

Examining the current status of novel treatments and research efforts to identify novel targets in the era of stratified medicines in severe asthma.

July 2015

Article in Thorax - 23 July 2015

Description of the RASP study and it's aims.

January 2015

Press Release - 29 January 2015

Press release to announce the awarding of an MRC grant to RASP UK.

Asthma UK press release describing the MRC support for the programme

Asthma UK: Announcing the award of the grant funding by the MRC.